SAM
ITOS

Sectoral Asset Management’s iTeos Therapeutics ITOS Stock Holding History

Sectoral Asset Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,650
Closed -$160K – 95
2024
Q3 		$160K Sell
15,650
-81,316
-84% -$1.24M 0.09% 87
2024
Q2 		$1.44M Sell
96,966
-37,000
-28% -$530K 0.58% 48
2024
Q1 		$1.83M Sell
133,966
-86,090
-39% -$938K 0.72% 43
2023
Q4 		$2.41M Buy
220,056
+64,981
+42% +$644K 1.04% 35
2023
Q3 		$1.7M Buy
155,075
+8,499
+6% +$109K 0.33% 89
2023
Q2 		$1.94M Buy
146,576
+58,203
+66% +$830K 0.32% 87
2023
Q1 		$1.2M Buy
88,373
+30,611
+53% +$548K 0.23% 92
2022
Q4 		$1.13M Buy
+57,762
New +$1.13M 0.22% 95
2022
Q3 		– Sell
-147,900
Closed -$3.05M – 111
2022
Q2 		$3.05M Sell
147,900
-86,250
-37% -$2.05M 0.61% 65
2022
Q1 		$7.54M Buy
234,150
+154,150
+193% +$5.6M 1.34% 29
2021
Q4 		$3.73M Sell
80,000
-193,700
-71% -$6.45M 0.56% 67
2021
Q3 		$7.39M Buy
273,700
+266,000
+3,455% +$6.95M 0.61% 67
2021
Q2 		$198K Buy
+7,700
New +$183K 0.02% 127

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Sectoral Asset Management's ITOS Position: Q4 2024 in Review

Sectoral Asset Management sold out of iTeos Therapeutics (ITOS) in Q4 2024, closing a stake of 15,650 shares — an estimated $160K sold.

Sectoral Asset Management first reported a position in ITOS in Q2 2021 and held it in 13 quarters. The position peaked at $7.54M in Q1 2022. 136 funds tracked by Wall St. Rank hold ITOS as of Q4 2024.

  • Sectoral Asset Management reported no remaining iTeos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 15,650 iTeos Therapeutics shares in Q4 2024, an estimated $160K.
  • Sectoral Asset Management first reported a position in iTeos Therapeutics in Q2 2021 and held it in 13 quarters.
  • Sectoral Asset Management's iTeos Therapeutics position peaked at $7.54M in Q1 2022.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2024.

Based on Sectoral Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.